Related by context. Frequent words. (Click for all words.) 62 mg kg dose 60 peginterferon 59 randomisation 58 MIRCERA 58 rotigotine 58 decitabine 58 placebo controlled clinical 58 COPAXONE R 57 plus methotrexate 57 active comparator 57 sinus rhythm 56 eszopiclone 56 infliximab 56 #mg dose [003] 56 hypokalemia 56 tamoxifen therapy 56 REMICADE ® 56 degarelix 56 adalimumab 56 double blinded placebo 56 virologic response 56 abatacept 56 mg QD 56 mcg kg 56 lamotrigine 56 anticoagulation therapy 56 fibrinolysis 55 bisphosphonate therapy 55 peg IFN 55 oral corticosteroids 55 mcg dose 55 dose regimens 55 pramipexole 55 lymphopenia 55 mg BID 55 cytogenetic response 55 LIALDA 55 divalproex 55 aripiprazole 55 administered subcutaneously 55 warfarin therapy 55 phase IIa 55 cerebrovascular events 55 peginterferon alfa 2a 55 etanercept 55 tiotropium 55 lacosamide 55 placebo controlled studies 54 COPD exacerbations 54 virologic failure 54 postoperatively 54 coronary revascularization 54 nortriptyline 54 ziprasidone 54 interferon therapy 54 dose cohorts 54 Phase 1a 54 COPAXONE ® 54 esomeprazole 54 median PFS 54 montelukast 54 mitoxantrone 54 tocilizumab 54 TORISEL 54 galantamine 54 azacitidine 54 achieved statistical significance 54 Gabapentin GR 54 anakinra 54 PROMACTA 54 #mg dose [001] 54 erosive esophagitis 54 placebo controlled randomized 54 colectomy 53 alvimopan 53 hypomagnesemia 53 events AEs 53 chemoradiotherapy 53 octreotide 53 dose escalation 53 mycophenolate mofetil 53 FOLFIRI 53 androgen deprivation 53 Secondary endpoints 53 nitazoxanide 53 Torisel 53 cardiac toxicity 53 Secondary endpoints include 53 citalopram 53 antidepressant therapy 53 EBRT 53 secondary efficacy endpoints 53 tipranavir 53 tumor resection 53 pregabalin 53 annualized relapse 53 Sandostatin LAR 53 virologic 53 Phase 2a trial 53 nab paclitaxel 53 certolizumab pegol